CXCL10 and neoplasm: Ablation of USP15 increases TET2 binding to Cxcl9, Cxcl10, and Cxcl11 promoters, which trigger the production of IFN-γ chemokines and boosts tumor-infiltrating lymphocytes to improve the responsiveness to anti-PD-L1 treatment [152].